May 11, 2016
May 11, 2016 —
In a massive analysis of DNA samples from more than 13,000 U.S. soldiers, scientists have identified two statistically significant genetic variants that may be associated with an increased risk of post-traumatic stress disorder (PTSD), an often serious mental illness linked to earlier exposure to a traumatic event, such as combat and an act of violence.
May 10, 2016
May 10, 2016 —
In Alzheimer’s disease, plaques of amyloid beta protein accumulate in the brain, damaging connections between neurons. Now, researchers at University of California San Diego School of Medicine and Harvard Medical School have found that the enzyme Protein Kinase C (PKC) alpha is necessary for amyloid beta to damage neuronal connections. They also identified genetic variations that enhance PKC alpha activity in patients with Alzheimer’s disease.
May 10, 2016
May 10, 2016 —
A new technology in the Neonatal Intensive Care Unit (NICU) at UC San Diego Health is able to predict the risk of life-threatening infections up to 24 hours before they appear in severely premature or critically ill infants. Infection is the leading cause of death in this fragile patient population.
May 9, 2016
May 9, 2016 —
UC San Diego Health has been named by Becker’s Hospital Review to its 2016 list of “100 Great Hospitals in America.” The list is based on rankings and awards from reputable sources, such as Healthgrades, The Leapfrog Group, and U.S. News & World Report. The list honors 100 hospitals considered health care leaders in their region, state or the nation.
May 6, 2016
May 6, 2016 —
For the first time, researchers at University of California San Diego School of Medicine have determined one way Zika virus infection can damage developing brain cells. The study, published May 6 in Cell Stem Cell, also shows that inhibiting this mechanism reduces brain cell damage, hinting at a new therapeutic approach to mitigating the effects of prenatal Zika virus infection.
May 4, 2016
May 4, 2016 —
Researchers at University of California San Diego School of Medicine have demonstrated that distinct types of glioblastoma, the most common form of brain cancer in adults, tend to develop in different regions of the brain. This finding provides an explanation for how the same cancer-causing mutation can give rise to different types of brain malignancies.
May 4, 2016
May 4, 2016 —
Researchers at University of California San Diego School of Medicine have shown that ozanimod (RPC1063), a novel drug molecule, is moderately effective in the treatment of ulcerative colitis. Results of the Phase II clinical trial will appear in the May 5 issue of the New England Journal of Medicine.
May 2, 2016
May 2, 2016 —
Two researchers with the San Diego Supercomputer Center (SDSC) at the University of California San Diego are editors of a just-published book that explores the latest developments in electronic structure calculations on modern computer hardware and explains how graphics processing units (GPUs) can be efficiently exploited to perform such calculations more rapidly than previously possible.
May 2, 2016
May 2, 2016 —
Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.
May 2, 2016
May 2, 2016 —
Local philanthropists Gary and Mary West have provided $11.8 million to the University of California San Diego to create a state-of-the-art senior emergency care unit to be housed within the Emergency Department at the future Jacobs Medical Center. The Gary and Mary West Senior Emergency Care Unit will enhance care for older adults and enable a multi-year medical research initiative in partnership with the West Health Institute to support their mission of making successful aging a reality for seniors in San Diego and the nation.
